The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma

Erlotinib, a tyrosine kinase inhibitor, has been shown to improve the survival of patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer. Sarcopenia is a status with increasing importance in lung cancer, and it may predict a poor prognosis. We aimed to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Topcu, Atakan, Ozturk, Akin, Yurtsever, Ismail, Besiroglu, Mehmet, Yasin, Ayse Irem, Turk, Haci Mehmet, Seker, Mesut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589317/
https://www.ncbi.nlm.nih.gov/pubmed/35575465
http://dx.doi.org/10.17305/bjbms.2022.7147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589317/
https://www.ncbi.nlm.nih.gov/pubmed/35575465
http://dx.doi.org/10.17305/bjbms.2022.7147

Ejemplares similares